Loading stock data…
ATR
$119.02-4.66 (-3.77%)
Market ClosedLast close May 1
AptarGroup, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AptarGroup, Inc. in the Healthcare sector is trading at $119.02. The stock is currently 28% below its 52-week high of $164.28, remaining 8.6% below its 200-day moving average. Technical signals show oversold RSI of 23 and bearish MACD signal, explaining why ATR maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 23) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$119.02
Potential Downside
1.5%
Whystock Fair Value$117.26
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus7 analysts
Buy
Mean target$163.14+37.1%
Range$144.00 – $220.00
Fundamentals
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and bever...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.04B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.25
Beta
Defensive asset. Lower volatility than the S&P 500.
0.49
Div Yield
Strong income play. Yield provides a meaningful total return floor.
149.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.67%
Volume
Today's trading volume
888,030
Recent News
Earnings Update: AptarGroup, Inc. (NYSE:ATR) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Shareholders might have noticed that AptarGroup, Inc. ( NYSE:ATR ) filed its quarterly result this time last week. The...
AptarGroup Inc (ATR) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ...
AptarGroup Inc (ATR) reports an 11% sales increase, driven by robust demand in injectables and consumer healthcare, despite margin pressures and segment-specific hurdles.
Assessing AptarGroup (ATR) Valuation After First Quarter Earnings Beat And Profit softness
AptarGroup (ATR) has drawn fresh attention after reporting first quarter 2026 results that topped consensus forecasts for both earnings and revenue, even though net income and earnings per share were lower than a year earlier. See our latest analysis for AptarGroup. Even with the earnings and revenue beat, AptarGroup’s recent share price performance has been weak, with a 30 day share price return decline of 6.1% and a 1 year total shareholder return decline of 20.9%, pointing to fading...
AptarGroup Q1 Earnings Call Highlights
AptarGroup (NYSE:ATR) reported first-quarter 2026 results that management said largely tracked expectations, with currency providing a lift to reported growth while underlying performance reflected mixed conditions tied mainly to an expected destocking cycle in emergency medicine. On the call, Pres
AptarGroup, Inc. Q1 2026 Earnings Call Summary
Moby summary of AptarGroup, Inc.'s Q1 2026 earnings call